Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710

Cancer

Volumn 120, Issue 8, 2014, Pages 1272-1280

  Christodouleas, John P ^a   Baumann, Brian C ^a   He, Jiwei ^b   Hwang, Wei Ting ^b   Tucker, Kai N ^a   Bekelman, Justin E ^a   Tangen, Catherine M ^c   Lerner, Seth P ^d   Guzzo, Thomas J ^b   Malkowicz, S Bruce ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

adjuvant radiation; bladder cancer; local failure; urothelial cancer

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER LOCALIZATION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; DRUG EFFICACY; FEMALE; HUMAN; LOCOREGIONAL FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; TREATMENT FAILURE;

ADJUVANT RADIATION; BLADDER CANCER; LOCAL FAILURE; UROTHELIAL CANCER;

ADULT; AGED; COHORT STUDIES; CYSTECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK; URINARY BLADDER NEOPLASMS;

EID: 84898046169     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28544     Document Type: Article

References (20)

1. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003; 349: 859-866
2. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004; 22: 2781-2789.
3. Baumann BC, Guzzo TJ, He J, et al. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Int J Radiat Oncol Biol Phys. 2013; 85: 81-88.
4. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001; 19: 666-675.
5. Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003; 21: 690-696.
6. Millikan R, Dinney C, Swanson D, et al. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol. 2001; 19: 4005-4013.
7. Hassan JM, Cookson MS, Smith JA Jr, Chang SS,. Patterns of initial transitional cell recurrence in patients after cystectomy. J Urol. 2006; 175: 2054-2057.
8. Advanced Bladder Cancer Overview Collaboration. Neoadjuvant chemotherapy for invasive bladder cancer [serial online]. Cochrane Database Syst Rev. 2005;(2): CD005246.
9. Volkmer BG, Kuefer R, Bartsch GC Jr, Gust K, Hautmann RE,. Oncological follow-up after radical cystectomy for bladder cancer-is there any benefit? J Urol. 2009; 181: 1587-1593.
10. Cole CJ, Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC,. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone. Int J Radiat Oncol Biol Phys. 1995; 32: 331-340.
11. Pollack A, Zagars GK, Cole CJ, Dinney CP, Swanson DA, Grossman HB,. The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol. 1995; 154: 2059-2063.
12. International Collaboration of Trialists, Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Res. Institute Bladder Cancer Clinical Studies Group), European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group, et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol. 2011; 29: 2171-2177.
13. Ide H, Kikuchi E, Miyajima A, et al. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer. Jpn J Clin Oncol. 2008; 38: 360-264.
14. Skinner EC, Stein JP, Skinner DG,. Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol. 2007; 25: 66-71.
15. Zaghloul MS, Awwad HK, Akoush HH, Omar S, Soliman O, el Attar I,. Postoperative radiotherapy of carcinoma in bilharzial bladder: improved disease free survival through improving local control. Int J Radiat Oncol Biol Phys. 1992; 23: 511-517.
16. Cozzarini C, Pellegrini D, Fallini M, et al. Reappraisal of the role of adjuvant radiotherapy in muscle-invasive transitional cell carcinoma of the bladder [abstract]. Int J Radiat Oncol Biol Phys. 1999; 45: 221-222.
17. Baumann BC, Guzzo TJ, He J, et al. Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2013; 85: 363-369.
18. Noa K, Dolney D, Baumann BC, Bekelman JE, Christodouleas JP,. Adjuvant radiation for bladder cancer: a dosimetry study [abstract]. Int J Radiat Oncol Biol Phys. 2012; 84: S420.
19. Shariat SF, Margulis V, Lotan Y, Montorsi F, Karakiewicz PI,. Nomograms for bladder cancer. Eur Urol. 2008; 54: 41-53.
20. Reisinger SA, Mohiuddin M, Mulholland SG,. Combined pre- and postoperative adjuvant radiation therapy for bladder cancer-a ten year experience. Int J Radiat Oncol Biol Phys. 1992; 24: 463-468.